The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.1077+1G>T

CA16041867

370482 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: dbfa454a-78d2-4c11-b4a1-d91bb22dc523

HGVS expressions

NM_000018.4:c.1077+1G>T
NM_000018.4(ACADVL):c.1077+1G>T
NC_000017.11:g.7222866G>T
CM000679.2:g.7222866G>T
NC_000017.10:g.7126185G>T
CM000679.1:g.7126185G>T
NC_000017.9:g.7066909G>T
NG_007975.1:g.8033G>T
NG_008391.2:g.2185C>A
ENST00000356839.10:c.1077+1G>T
ENST00000322910.9:c.*1032+1G>T
ENST00000350303.9:c.1011+1G>T
ENST00000356839.9:c.1077+1G>T
ENST00000543245.6:c.1146+1G>T
ENST00000578824.5:n.227G>T
ENST00000582379.1:n.462G>T
ENST00000583858.5:n.106+1G>T
ENST00000585203.6:n.19G>T
NM_000018.3:c.1077+1G>T
NM_001033859.2:c.1011+1G>T
NM_001270447.1:c.1146+1G>T
NM_001270448.1:c.849+1G>T
NM_001033859.3:c.1011+1G>T
NM_001270447.2:c.1146+1G>T
NM_001270448.2:c.849+1G>T

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"
Met criteria codes 2
PVS1 PM2_Supporting
Not Met criteria codes 1
PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1077+1G>T variant in ACADVL is a splice site variant affecting the canonical donor splice site in intron 10. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present at low frequency (1 allele, <0.1%) in large population database (PM2_supporting, gnomad). This variant has been reported in abnormal newborn screen with 36% residual enzyme activity (PP4 not met) without clinical confirmation or a second variant identified (PMID 21932095). In summary, this variant meets criteria to be classified as likely pathogenic for VLCAD in an AR manner. ACADVL-specific ACMG/AMP criteria applied: PVS1, PM2_supporting.
Met criteria codes
PVS1
c.1077+1G>T affects canonical donor splice site in intron 10 which is predicted to disrupt splicing causing the skipping of exon 10, which would lead to frameshift, premature stop codon, and NMD.
PM2_Supporting
1 allele observed (<0.1%) in population database (gnomad)
Not Met criteria codes
PP4
Clinical information and confirmatory study not provided. A second potential disease causing variant not identified. 36% residual enzyme does not meet PP4.
Approved on: 2022-09-22
Published on: 2022-09-22
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.